As 5-AZA, a classical DNMT inhibitor, conjunct with mice vaccination or DCs fusions could similarly elicit anti-tumor immunity via elevating the prefoliation of CD8+ T cells and increasing overall survival in diverse tumor models [197, 198], the strong connection between DNA methylation and immune-related genes in DCs has been uncovered [199]. Here, CD8A is linked to neoplasm.